Kathua rape victim sank into coma due to overdose of sedatives, say forensic experts

The Crime Branch decided to seek medical opinion after it was claimed by the accused that it was virtually impossible that the girl could not have cried for help.

June 24, 2018 07:03 pm | Updated December 01, 2021 06:07 am IST - Jammu/New Delhi

 Heavy security deployed outside the Judicial Courts Complex during the trial of Kathua rape and murder case, in Pathankot, Punjab. File

Heavy security deployed outside the Judicial Courts Complex during the trial of Kathua rape and murder case, in Pathankot, Punjab. File

Overdose of sedatives, forcibly administered to an eight-year-old rape victim during her captivity in Kathua in January 2018, could have pushed her into coma before she was killed, forensic medical experts have said.

The Crime Branch of the Jammu and Kashmir Police, probing the gang rape and murder case, sent a sample of her viscera to a forensic laboratory earlier this month to examine the effect of “mannar” candies (believed to be local cannabis) and Epitril 0.5 mg tablets, administered to the girl by her captors.

According to the medical opinion received recently by the Crime Branch, the doctors said the tablet given to the eight-year-old girl could have pushed her into a state of shock or coma (loss of consciousness).

The Crime Branch had asked the medical experts to comment upon the plausible effect of the medicine on an eight-year-old girl with an empty stomach.

The Crime Branch decided to seek further medical opinion after it was claimed by the accused and their lawyers in the court, as well as on social media through their supporters, that it was virtually impossible that the girl could not have cried for help when such an alleged brutal attack was happening on her.

'Forcefully administered tablets'

The doctors, after examining the viscera, opined that the medicine administered to the victim contained Clonazepam salt and had to be administered under medical supervision keeping in mind the age and weight of the patient.

“Considering her [victim] 30-kg body weight, the therapeutic dose of 0.1 to 0.2 mg per day divided in three doses for patient [is recommended],” it said.

“She was forcefully administered five tablets of Clonazepam of 0.5 mg each on January 11, 2018 which is higher than the safe therapeutic dose. Subsequently more tablets were given… the signs and symptoms of an overdose may include drowsiness, confusion, impaired coordination, slow reflexes, slowed or stopped breathing, coma [loss of consciousness] and death,” according to the opinion of the medical expert.

The peak concentration of Clonazepam is achieved in the blood after one hour to 90 minutes of oral administration and its absorption is complete, “irrespective of administered either with or without food”, according to the concluding opinion of the medical expert.

No analysis on 'mannar'

The opinion would be submitted before the district and sessions court in Punjab’s Pathankot, hearing the matter, after the summer break next week.

The trial of the case was shifted from Kathua (in Jammu) to Pathankot on the directions of the Supreme Court.

The doctors said the risk is higher if Clonazepam is “concomitant used with other CNS [central nervous system] depressants like alcohol...”

The doctors, however, could not give any laboratory analysis of ‘mannar’ candies and said “it is difficult to comment on the effect its co-administration with Clonazapem” would have.

‘Mannar’ is locally available cannabis, which keeps a person sedated for a few hours.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.